Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future prospects for calcium antagonists

S Kazda1

  • 1Abteilung Hypertonie, Institut für Herz-Kreislauf und Arteriosklerose-Forschung, Bayer AG, Wuppertal, Germany.

Drugs
|January 1, 1994
PubMed
Summary

Calcium antagonists (CA) are vital in managing hypertensive disease by targeting vascular resistance. Future applications may include early hypertension stages and preventing tissue damage in advanced disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Clinical outcomes of surgical management of acromioclavicular dislocation with and without ligament suturing].

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2012
Same author

[Comparative clinical study assessing C2 dens injuries treatment outcomes].

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2010
Same author

Long-term blockade of the angiotensin II receptor in renin transgenic rats, salt-loaded Dahl rats, and stroke-prone spontaneously hypertensive rats.

Arzneimittel-Forschung·1997
Same author

Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs.

Clinical and experimental hypertension (New York, N.Y. : 1993)·1995
Same author

Effect of nifedipine on coronary capillary geometry in normotensive and hypertensive rats.

Hypertension (Dallas, Tex. : 1979)·1994
Same author

Cardiac structural remodelling after treatment of spontaneously hypertensive rats with nifedipine or nisoldipine.

Cardiovascular research·1993

Area of Science:

  • Cardiovascular Pharmacology
  • Nephrology
  • Vascular Biology

Background:

  • Hypertensive disease involves increased vascular resistance, a key factor targeted by calcium antagonists (CA).
  • Current understanding of CA primarily focuses on established hypertension, with potential for earlier intervention.

Purpose of the Study:

  • To explore the extended therapeutic potential of calcium antagonists in various stages of hypertensive disease.
  • To investigate the mechanisms by which CA preserve tissue integrity and impact vascular pathologies.

Main Methods:

  • Review of existing literature on calcium antagonist mechanisms in hypertension.
  • Analysis of preclinical data on nifedipine's protective effects in nonvascular tissues.

Main Results:

  • Calcium antagonists impact the primary mechanism of elevated vascular resistance in hypertension.
  • CA show promise in preventing vascular remodeling and mitigating renal and cardiac damage in advanced hypertension.
  • Nifedipine exhibits protective effects against toxic and radiation-induced tissue damage in animal models, independent of blood pressure reduction.

Conclusions:

  • Calcium antagonists are likely to see expanded use in early and advanced hypertension.
  • CA preserve tissue integrity and reverse vascular pathologies like arteriosclerosis and microangiopathy through calcium overload prevention.
  • The tissue-protective properties of specific calcium antagonists warrant further investigation.

Related Experiment Videos